4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-035032
Director acquired 7,333 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Humphries William D. Director | 2020-06-06 | Option exercise | +7,333 | 16,209 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Humphries William D. Director | 2020-06-04 | Grant or award · Option Grant (right to buy) | +16,500 | 16,500 | D: show line 2 in the form | |||||
| Humphries William D. Director | 2020-06-06 | Option exercise · Restricted Stock Units | −7,333 | 0 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…